Considering that Pirfenidone is metabolised through the CYP1A2 enzyme pathway, any drug which inhibits this enzyme is likely to precipitate the toxicity of pirfenidone: concomitant therapy would be to be averted. Despite the fact that GB1275 has not been assessed to date in animal designs of prostate, colorectal, gastric, or https://jessicax110puc4.bloggadores.com/profile